Chattem Acquires Worldwide Rights to ACT

Chattem Inc. announces the closing of its previously announced agreement to acquire the rights to ACT, a branded over-the-counter (OTC) anti-cavity mouthwash/mouth rinse, in Western Europe with worldwide trademark rights from Johnson & Johnson for $4.1 million in cash plus certain assumed liabilities. Chattem acquired the U.S. rights to ACT from Johnson & Johnson as a part of its acquisition of five OTC brands in a transaction that closed on January 2, 2007.